DE69404370D1 - Gelatinase A zur Behandlung von der Alzheimerschen Krankheit - Google Patents

Gelatinase A zur Behandlung von der Alzheimerschen Krankheit

Info

Publication number
DE69404370D1
DE69404370D1 DE69404370T DE69404370T DE69404370D1 DE 69404370 D1 DE69404370 D1 DE 69404370D1 DE 69404370 T DE69404370 T DE 69404370T DE 69404370 T DE69404370 T DE 69404370T DE 69404370 D1 DE69404370 D1 DE 69404370D1
Authority
DE
Germany
Prior art keywords
gelatinase
alzheimer
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69404370T
Other languages
English (en)
Other versions
DE69404370T2 (de
Inventor
Kaouru Miyazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oriental Yeast Co Ltd
Original Assignee
Oriental Yeast Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oriental Yeast Co Ltd filed Critical Oriental Yeast Co Ltd
Publication of DE69404370D1 publication Critical patent/DE69404370D1/de
Application granted granted Critical
Publication of DE69404370T2 publication Critical patent/DE69404370T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69404370T 1993-04-27 1994-04-25 Gelatinase A zur Behandlung von der Alzheimerschen Krankheit Expired - Lifetime DE69404370T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12220793 1993-04-27
JP05113394A JP3466259B2 (ja) 1993-04-27 1994-02-25 βＡＰ分解剤

Publications (2)

Publication Number Publication Date
DE69404370D1 true DE69404370D1 (de) 1997-08-28
DE69404370T2 DE69404370T2 (de) 1997-11-20

Family

ID=26391663

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69404370T Expired - Lifetime DE69404370T2 (de) 1993-04-27 1994-04-25 Gelatinase A zur Behandlung von der Alzheimerschen Krankheit

Country Status (4)

Country Link
US (1) US5843695A (de)
EP (1) EP0622079B1 (de)
JP (1) JP3466259B2 (de)
DE (1) DE69404370T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140309A (en) * 1996-03-12 2000-10-31 University Of South Florida Vasoactive effects and free radical generation by β-amyloid peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902680A (en) * 1984-10-29 1990-02-20 Chaovanee Aroonsakul Treating central nervous system diseases
US5221607A (en) * 1989-09-18 1993-06-22 Scios Nova Inc. Assays and reagents for amyloid deposition
US5252463A (en) * 1990-06-22 1993-10-12 The Du Pont Merck Pharmaceutical Company Clipsin, a chymotrypsin-like protease and method of using same
WO1992003542A1 (en) * 1990-08-17 1992-03-05 Boston University PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR

Also Published As

Publication number Publication date
EP0622079A2 (de) 1994-11-02
JPH0789870A (ja) 1995-04-04
US5843695A (en) 1998-12-01
EP0622079A3 (de) 1995-08-09
JP3466259B2 (ja) 2003-11-10
EP0622079B1 (de) 1997-07-23
DE69404370T2 (de) 1997-11-20

Similar Documents

Publication Publication Date Title
FI962557A0 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
DE69227883T2 (de) Riechstoffmikrokapseln zur Behandlung von Wäsche
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
DE69304955T2 (de) Behandlung von neurodegenerativen Erkrankungen
DE69124293T2 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
NO944928D0 (no) Fremgangsmåter for inhibering av Alzheimers sykdom
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69841421D1 (de) Die verwendung von einem steroidsaponin zur behandlung von demenz
DE69429160D1 (de) Behandlung von textilprodukt
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
DE69405711D1 (de) Behandlung von rueckstandsoel
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69805305T2 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
DE69212119D1 (de) Behandlung von Fotoresistabfall
DE69404370T2 (de) Gelatinase A zur Behandlung von der Alzheimerschen Krankheit
NO941014D0 (no) Jordbehandlingsprosess
DE689838T1 (de) Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen
DE69306260T2 (de) Behandlung von abwasser
NO961180D0 (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
DE69413325D1 (de) 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis
DE69314086D1 (de) Verfahren zur Reinigung von 4,4'-Diaminodiphenylmethan
DE69102284T2 (de) Beseitigung von dichlormethan.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition